Thailand to start using AstraZeneca vaccine Tuesday after delay over safety | Inquirer News

Thailand to start using AstraZeneca vaccine Tuesday after delay over safety

/ 03:19 PM March 15, 2021

Thailand to start using AstraZeneca vaccine Tuesday after delay over safety

FILE PHOTO: A vial of the Oxford-AstraZeneca COVID-19 vaccine is seen at Basingstoke Fire Station, in Basingstoke, Britain February 4, 2021. REUTERS/Peter Cziborra

BANGKOK — Thailand will start using the AstraZeneca COVID-19 vaccine on Tuesday after a brief delay due to concerns over its safety, officials said, with the prime minister and his cabinet due to be the first to receive it.

Natreeya Thaweewong, director of the spokesperson’s office of government house, made the announcement about the inoculations, which were delayed from Friday, in a chat group with media on Monday.

Health Minister Anutin Charnvirakul had earlier on Monday said the AstraZeneca vaccine, over which there have been reports in Europe of sporadic blood clots, would be given to the cabinet on Tuesday if cleared by local health experts.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Thailand

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.